鞘内药物输注技术用于癌痛管理的中国专家共识(2022版)  

Expert consensus on intrathecal drug delivery technology for cancer pain management in China(2022)

作　　者：冯智英[1] 王昆 金毅 路桂军 吕岩 马柯[6] 宋涛[7] 孙涛 金晓红[9] 王亚平[10] 谢广伦 肖红[12] 肖礼祖 杨东[14] 姚明[15] Feng Zhiying;Wang Kun;Jin Yi;Lu Guijun;Lv Yan;Ma Ke;Song Tao;Sun Tao;Jin Xiaohong;Wang Yaping;Xie Guanglun;Xiao Hong;Xiao Lizu;Yang Dong;Yao Ming(Department of Pain Medicine,The First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou City,Zhejiang Province 310003,China;Department of Pain Management,Tianjin Medical University Cancer Institute and Hospital,Tianjin City 300060,China;Department of Pain Medicine,The General Hospital of Eastern Theater,PLA,Nanjing City,Jiangsu Province 210002,China;Department of Pain Medicine,Tsinghua Changgung Hospital,Beijing City 102218,China;Department of Pain Medicine,Xijing Hospital,The Fourth Military Medical University,Xi'an City,Shaanxi Province 710032,China;Department of Algology,Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai City 200092,China;Department of Pain Medicine,The First Hospital of China Medical University,Shenyang City,Liaoning Province 110001,China;Departments of Pain Management,Shandong Provincial Hospital Affiliated to Shandong First Medical University,Jinan City,Shandong Province 250021,China;Department of Pain Management,The First Affiliated Hospital of Soochow University,Suzhou City,Jiangsu Province 215031,China;Department of Pain Management and Anesthesiology,The Second Xiangya Hospital,Central South University,Changsha City,Hunan Province 410011,China;Department of Pain&Rehabilitation and Palliative Medicine,Affiliated Cancer Hospital of Zhengzhou University,Zhengzhou City,Henan Province 450000,China;Department of Pain Management,West China Hospital of Sichuan University,West China Hospital of Sichuan University,Wuhou District,Chengdu City,Sichuan Province 610041,China;Department of Pain Medicine,Huazhong University of Science and Technology Union Shenzhen Hospital(Nanshan Hospital),Shenzhen City,Guangdong Province 518052,China;Department of Pain Medicine,Institute of Anesthesiology and Critical Care Medicine,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan

机构地区：[1]浙江大学医学院附属第一医院疼痛科,杭州市310003 [2]天津医科大学肿瘤医院疼痛治疗科,天津市300060 [3]东部战区总医院疼痛科,南京市210002 [4]北京清华长庚医院疼痛科,北京市102218 [5]空军军医大学西京医院痛科,西安市710032 [6]上海交通大学医学院附属新华医院疼痛科,上海市2200092 [7]中国医科大学附属第一医院疼痛科,沈阳市110001 [8]山东第一医科大学附属省立医院疼痛科,济南市250021 [9]苏州大学附属第一医院疼痛科,苏州市215031 [10]中南大学湘雅二医院疼痛科,长沙市410011 [11]郑州大学附属肿瘤医院疼痛康复与姑息医学科,郑州市450000 [12]四川大学华西医院疼痛科,成都市610041 [13]华中科技大学协和深圳医院疼痛科,深圳市518052 [14]华中科技大学同济医学院附属协和医院疼痛科,武汉市430022 [15]嘉兴学院附属医院疼痛科,嘉兴市314001

出　　处：《中华疼痛学杂志》2022年第5期579-589,共11页Chinese Journal Of Painology

基　　金：浙江省"领雁"研发攻关计划前沿创新诊疗设备研发-闭环管理脊髓电刺激治疗难治性慢性疼痛的研发及应用(编号2022C03081)。

摘　　要：肿瘤患者癌痛高发,且严重影响其生活质量。鞘内药物输注技术(IDD)用于癌痛管理的有效性和安全性已被证实,目前国内临床应用日趋增多和普及。为规范该技术,推动IDD临床合理应用,《中华疼痛学杂志》编委会组织国内相关专家,参考国内外诊疗指南、临床研究和临床实践,深入探讨该技术应用于癌痛患者的适应证、禁忌证、手术操作、并发症防治以及围术期管理等问题,形成本专家共识,予以发布。Cancer pain is a prevalent symptom in cancer patients and seriously affects patients'quality of life.Intrathecal drug delivery(IDD)have been widely recognized in effectiveness and safety and is promoted and popularized in cancer pain management now.In order to better regulate this technology and promote rational clinical use of IDD,Chinese Journal of Painology gathered domestic experts with rich clinical experience in this technology,to integrate the existing domestic and foreign clinical guidelines,clinical research and practice,and to form this consensus about IDD in indications,contraindications,operative techniques,prevention and management of complications and perioperative management for cancer pain treatment.

关 键 词：癌症疼痛 鞘内镇痛 鞘内药物输注系统 

分 类 号：R730.5[医药卫生—肿瘤]